Navigation Links
Olympus Capital Announces Agreement to Sell Arysta LifeScience Corporation
Date:10/22/2007

JPY 50 billion of distribution companies and product lines around the world to further bolster the company's global coverage and product portfolio.

"As part of our partnership with Tomen and Nichimen to catalyze change in Arysta, we had the opportunity to bring in a number of world-class executives to the company, both in Japan and to the global operations," said David Shen, Managing Director of Olympus Capital in Tokyo and an Arysta Board Member. "This management team has done a superb job of executing the business plan, resulting in more than doubling of profitability. Together with management, we have seen Arysta successfully develop into a leading global agrochemical company and we are very grateful for the tremendous effort of the Arysta management team and employees throughout its global operations."

Mr. Shen further added: "This investment illustrates Olympus Capital's commitment in Japan and throughout the region to working closely with management and our strategic partners to grow portfolio companies both organically and through acquisitions, and to increase profitability based on jointly-agreed business plans."

Completion of the transaction, which is subject to regulatory review and approvals, is anticipated to occur in the first quarter of 2008.

About Olympus Capital

Olympus Capital Holdings Asia is a leading middle market private equity firm specializing in partnering with Asian shareholders and management teams to expand their businesses regionally and globally. The firm's investment and operating professionals are located in offices in Tokyo, Delhi, Hong Kong, Seoul, Shanghai and New York. Since its establishment in 1997, Olympus Capital has invested over US$1.2 billion on behalf of funds and co-investors in more than 25 portfolio companies throughout Asia.

Olympus Capital, one of the early entrants to the Japan private equity market, completed its first Japanese investments in partnership with a major Japanese bank
'/>"/>

SOURCE Olympus Capital Holdings Asia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Breaking down Wisconsins angel capital numbers
2. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
3. Visions: Broderick says Wisconsin should be in top third in venture capital
4. In pursuit of capital, be sure to track your private offering
5. Wisconsin building toward the major leagues of venture capital
6. Research explains why women lack equal access to angel capital
7. When raising capital, why use a Private Placement Memorandum?
8. Capital-raising term sheets for angels and venture capitalists
9. Early Stage, Step 9: Raising capital in the securities landscape
10. Translating the language of capital-raising
11. Visions: Carbone bullish on Wisconsin venture capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... for judgment notwithstanding the verdict, a new trial, and ...
(Date:2/26/2015)... , Feb. 26, 2015   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... Ph.D., President and Chief Executive Officer of Regulus, will ... 35 th Annual Healthcare Conference on Wednesday, March ... being held at the Boston Marriott Copley Place.  ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... motions for judgment notwithstanding the verdict, a new trial, ...
(Date:2/26/2015)... 26, 2015 The Pittcon 2015 ... the Ernest N. Morial Convention Center in New ... of February 19, 2015) displaying products and services ... and government labs. The Exposition will offer the ... limited to, analytical chemistry; drug discovery; nanotechnology; life ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2
... For the second year in a row, BioTrends Research ... companies in the Philadelphia region by the Philadelphia 100, a joint ... of Greater Philadelphia, and the Philadelphia Business Journal. , ... become an established player in the field of syndicated market research ...
... , , SEATTLE, Sept. 8 ... today that executives will present a corporate update at the ... Peter Thompson, M.D., FACP, president, chief executive officer and chairman ... president and chief financial officer, are scheduled to present on ...
... - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ... the Rodman Renshaw 11th Annual Healthcare Conference on ... will be held at the New York Palace Hotel from ... of the presentation will be available at: http://www.wsw.com/webcast/rrshq15/oncy ...
Cached Biology Technology:BioTrends Research Group is Recognized by the Philly 100 for the Second Consecutive Year 2Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2Media Advisory - Oncolytics Biotech Inc. to Present at Rodman Renshaw 11th Annual Healthcare Conference 2
(Date:2/24/2015)... report analyzes the worldwide markets for Face and Voice Biometrics in ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Middle East ... Latin America . Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... in the abundance of fish, shellfish, and other aquatic fauna ... in the sea: historical records show that species in rivers ... of these declines in freshwater species is frequently overlooked by ... 2009 issue of BioScience . , Authors Paul Humphries ...
... to any process by which a cell converts one ... of signal transduction involve ordered sequences of biochemical reactions ... and activated by second messengers, resulting in a signal ... the order of milliseconds in the case of ion ...
... of French scientists have found the dose of DHA (docosahexaenoic ... healthy men. In a research report appearing in the September ... http://www.fasebj.org ), the scientists show that a 200 mg dose ... that reliably predict cardiovascular problems, such as those related to ...
Cached Biology News:Shifting baselines confound river restoration 2
Recombinant Rat CINC-2 alpha, CF...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SGG (Sheep gamma globulin) lysine through amide bonds. This product is homologous to NP-BSA....
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Biology Products: